Summit Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Florida, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
601 Brickell Key Dr Ste 1000, Miami, Flo...Phone Number
(650) 382-0001Website
www.smmttx.comRevenue
$33.6 MillionStock Symbol
SMMTIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
5
1
1
1
1
About Summit Therapeutics
Summit Therapeutics is an international biopharmaceutical company focussed on the discovery and development of novel medicines to treat Duchenne muscular dystrophy. The company is headquartered in Cambridge, UK.Explore more
Summit Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Summit Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Summit Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Summit Therapeutics has new funding data
Click to see if Summit Therapeutics had a recent Job posting/layoffs
Check if Summit Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Summit Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Summit Therapeutics
Check out if Summit Therapeutics is spiking on competitors!
Product Launch: Get notified when Summit Therapeutics launches new products
Recommended Actions
Find VP level buyers at Summit Therapeutics
Find 2 more new buyers
Compare Similar Companies to Summit Therapeutics
Compare insights from companies similar to Summit Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Summit Therapeutics
$33.6M
201-500
Public
$1.2B
2003
RM
Rishma MerchantSenior Director and Chief of Staff, Clinical Operations
Company Profile Activity
Activity Insights
Summit Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Summit Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Summit Therapeutics.
Summit Therapeutics financials insights
Gather financial insights about Summit Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Stock Offering
$34.2M
2024
Share Placement
$200M
2025
Stock/Share Issuance
$500M
Stock/Share Issuance
$500M
Summit Therapeutics Tech Stack
A closer look at the technologies used by Summit Therapeutics
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Summit Therapeutics News & Media
Summit (SMMT) Reports Positive Phase III Overall Survival Data for Ivonescimab in Advanced NSCLC
Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the best high short interest stocks with highest upside potential. On May 31, Summit Therapeutics announced positive Phase III overall survival/OS results from the HARMONi-6 trial, which evaluated ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in patients with advanced squamous non-small cell lung cancer/NSCLC. The study showed that […]B7-H3 Becomes The Hottest Antigen In Oncology, And One NK Engager Enters Clinic
Issued on behalf of GT Biopharma, Inc. SAN FRANCISCO, May 18, 2026 /PRNewswire/ -- USA News Group News Commentary — For more than two decades, B7-H3 sat on the shortlist of theoretically perfect cancer drug targets that nobody could quite figure out how to hit. The protein is broadly...H.C. Wainwright Reduced its Price Goal on Summit Therapeutics Inc. (SMMT)
Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the 8 Most Promising Biotech Stocks to Buy Now. On May 4, H.C. Wainwright reduced its price goal on Summit Therapeutics Inc. (NASDAQ:SMMT) to $23 from $30. The firm also noted a weaker interim signal from HARMONi-3 and flagged added risk to the final squamous readout expected in […]Buy These 3 Clinical-Stage Biotechs Under $30 With Solid Cash Runways
Clinical-stage biotech is one of the few corners of the market where a sub-$30 share price genuinely matters: small-cap oncology names can re-rate violently around a single Phase 3 readout or FDA decision, and 2026 is stacked with catalysts. For retail investors scanning headlines, the question is rarely about valuation multiples (most of these companies ... Buy These 3 Clinical-Stage Biotechs Under $30 With Solid Cash Runways
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Summit Therapeutics
Sign Up For FreeTo access detailed company insights
Summit Therapeutics is an international biopharmaceutical company focussed on the discovery and development of novel medicines to treat Duchenne muscular dystrophy. The company is headquartered in Cambridge, UK.... Read More
